ArticleCureus2026
Solitary Fibrous Tumor of the Abdominal Wall With Long-Term Progressive Enlargement and Malignant Features.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Solitary fibrous tumor (SFT) is a rare mesenchymal neoplasm that usually arises from the pleura, while extrapleural cases are uncommon. Abdominal wall SFTs are exceedingly rare, and their biological behavior remains unpredictable, with limited long-term follow-up data. An 83-year-old man was incidentally found to have an 18 mm mass on the liver surface in 2008 but declined further evaluation. Sixteen years later, he presented with abdominal pain, and imaging demonstrated enlargement of the lesion to 71 mm. Contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) showed a well-circumscribed subperitoneal mass contiguous with the abdominal wall and supplied by the superior epigastric artery. Laboratory tests, including tumor markers, were within normal limits. Elective laparotomy revealed a smooth, well-demarcated mass continuous with the abdominal wall, and en bloc resection was performed. Histopathology showed spindle cell proliferation with necrosis and a mitotic count of two per 10 high-power fields. Immunohistochemistry was positive for cluster of differentiation 34 (CD34), CD99, B-cell lymphoma 2 (BCL2), and signal transducer and activator of transcription 6 (STAT6), with a Ki-67 index of 6%, confirming malignant SFT. This case illustrates that indolent-appearing SFTs may exhibit progressive enlargement and demonstrate malignant potential over time, even after a prolonged period of clinical quiescence. To our knowledge, this is the first reported case of an abdominal wall SFT with malignant transformation documented after extended follow-up. Given the potential for recurrence or metastasis, vigilant long-term surveillance is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.